The Scientist

» clinical trials and ecology

Most Recent

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

0 Comments

image: Mining the Outliers

Mining the Outliers

By | April 1, 2015

Even when a clinical trial fails, some patients improve. What can researchers learn from these exceptional responders?

0 Comments

image: Tracking Miracles

Tracking Miracles

By | April 1, 2015

A panel of oncologists discusses cases of exceptional responders, or cancer patients whose tumors disappear after a brief period of chemotherapy.

0 Comments

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

5 Comments

image: Opinion: Upgrading Cancer Prevention

Opinion: Upgrading Cancer Prevention

By | April 1, 2015

Preemptive detection and intervention will be key to easing the growing burden of cancer, particularly in developing countries.

1 Comment

image: Ebola Vax Trial Update

Ebola Vax Trial Update

By | March 26, 2015

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2015

Evolving Ourselves, The Man Who Touched His Own Heart, Bats, and The Invaders

1 Comment

image: Clinic Trial Problems Kept Mum

Clinic Trial Problems Kept Mum

By | February 11, 2015

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

0 Comments

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

image: Tamiflu Reviewed Again

Tamiflu Reviewed Again

By | January 30, 2015

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

1 Comment

Popular Now

  1. Exercise-Induced Muscle Factor Promotes Memory
  2. Illustrating #FieldworkFails
  3. Transmissible Cancers Plague Mollusks
  4. Single Bacterial Species Improves Autism-Like Behavior in Mice
Biosearch Technologies